Hormone therapy increases breast cancer mortality risk, study finds

October 14, 2015

The Boston Globe: "The new study was the largest randomly controlled clinical trial to look not just at who develops breast cancer, but who dies." The authors also said, "The women on hormone therapy were more likely to have their breast cancer diagnosed at a later stage than women in the placebo group, possibly because hormones make breasts denser and tumors more difficult to spot on mammograms." According to a co-author of the study, "The bottom line is to avoid hormone therapy, except for management of moderate to severe menopausal symptoms that impair quality of life" (Cooney, 2010).

This article was reprinted from kaiserhealthnews with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.